Related Experiment Video
Updated: Feb 15, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
MicroRNA-1271 functions as a metastasis and epithelial-mesenchymal transition inhibitor in human HCC by targeting the
Chao Li1, Yezhen Jiang1, Runchen Miao1
1Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Abstract:
MicroRNAs (miRNAs or miRs) have been shown to regulate hepatocellular carcinoma (HCC) metastasis. In the present study, we focused on the functions of miR-1271 in HCC metastasis. The downregulation of miR-1271 was found to be associated with to venous infiltration, an advanced TNM stage (III+IV stage) and a shorter survival time. Our in vitro and in vivo data demonstrated that miR-1271 prevented HCC cell migration and invasion, as well as the formation of lung metastatic clusters. In addition, miR-1271 was demonstrated to markedly inhibit the epithelial-mesenchymal transition (EMT) of HCC cells. Importantly, protein tyrosine phosphatase type IVA member 1 (PTP4A1) was identified as a direct downstream target of miR-1271 in HCC. Furthermore, we confirmed that the phosphorylation of c-Src at Tyr416 mediated by PTP4A1 was a potential anti-HCC mechanism of action of miR-1271. On the whole, our data indicate that miR-1271 inhibits HCC metastasis by targeting the PTP4A1/c-Src signaling pathway and may serve as a prospective cancer therapeutic target for HCC.
Insights
MicroRNA-1271 (miR-1271) inhibits hepatocellular carcinoma (HCC) metastasis by targeting the PTP4A1/c-Src pathway. Lower miR-1271 levels correlate with advanced HCC, indicating its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) metastasis is a major cause of mortality.
- MicroRNAs (miRNAs) play crucial roles in regulating cancer progression, including HCC metastasis.
- The specific role of miR-1271 in HCC metastasis requires further elucidation.
Purpose of the Study:
- To investigate the function of miR-1271 in hepatocellular carcinoma (HCC) metastasis.
- To identify the downstream targets and signaling pathways regulated by miR-1271 in HCC.
- To evaluate the potential of miR-1271 as a therapeutic target for HCC.
Main Methods:
- In vitro and in vivo assays were used to assess HCC cell migration, invasion, and metastasis.
- Quantitative real-time PCR and Western blotting were employed to analyze gene and protein expression.
- Luciferase reporter assays and rescue experiments were conducted to validate target genes.
Main Results:
- Downregulation of miR-1271 was significantly associated with venous infiltration, advanced TNM stage, and shorter survival in HCC patients.
- miR-1271 suppressed HCC cell migration, invasion, and lung metastasis formation in vitro and in vivo.
- miR-1271 inhibited epithelial-mesenchymal transition (EMT) in HCC cells.
- Protein tyrosine phosphatase type IVA member 1 (PTP4A1) was identified as a direct target of miR-1271.
- miR-1271 inhibited PTP4A1-mediated phosphorylation of c-Src at Tyr416, thereby suppressing HCC metastasis.
Conclusions:
- miR-1271 functions as a tumor suppressor in HCC metastasis.
- miR-1271 inhibits HCC metastasis by targeting the PTP4A1/c-Src signaling pathway.
- miR-1271 represents a promising therapeutic target for inhibiting HCC metastasis.
Related Concept Videos
MicroRNAs
MicroRNAs
Epithelial Tissues and Their Functions
Epithelial tissues provide the body's first line of protection from physical,...
Phase Transitions
Hypothalamic-Pituitary Axis
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

